Orthofix International | OFIX - Ebitda


Orthofix International reported $7.73M in EBITDA for its fiscal quarter ending in September of 2024.





Ebitda Change Date
Accuray USD -685K 900K Sep/2024
AngioDynamics USD -369K 2.01M Feb/2025
AtriCure USD 19.86M 2.06M Dec/2025
Dexcom USD 422.2M 53.8M Dec/2025
EDAP TMS EUR -4.92M 843K Sep/2025
Globus Medical USD 280.46M 27.86M Dec/2025
Hologic USD 330.4M 16.6M Dec/2025
Insulet USD 194M 34M Dec/2025
Integra LifeSciences USD 104.21M 25.76M Dec/2025
J&J USD 9.52B 389M Sep/2025
Medtronic USD 2.93B 482M Dec/2025
Mesa Laboratories USD 9.58M 1.47M Sep/2024
Orthofix International USD 7.73M 7.64M Sep/2024
Smith & Nephew USD 796M 139M Dec/2025
STAAR Surgical USD -159K 34.78M Dec/2025
Stryker USD 1.67B 206M Sep/2025
Surmodics USD 1.53M 485K Sep/2024
Tandem Diabetes Care USD 32.9M 30.13M Dec/2025
Teleflex USD -328.81M 536.43M Sep/2025
Veracyte USD 42.31M 2.58M Dec/2025
Zimmer Biomet Holdings USD 759M 120.8M Dec/2025